Last reviewed · How we verify
NCT05900037
GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery
NA trial testing GATT-Patch in Intraoperative Bleeding in 53 participants. Completed in 5 August 2025.
7 July 2025
Quick facts
| Lead sponsor | GATT Technologies BV |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 53 |
| Start date | 2 October 2023 |
| Primary completion | 7 July 2025 |
| Estimated completion | 5 August 2025 |
| Sites | 6 locations across United States |
Drugs / interventions tested
- GATT-Patch
- SURGICEL® Original — full drug profile →
Conditions studied
- Intraoperative Bleeding — all drugs for Intraoperative Bleeding →
- Liver Diseases — all drugs for Liver Diseases →
- Gallbladder Diseases — all drugs for Gallbladder Diseases →
- Hemorrhage, Surgical — all drugs for Hemorrhage, Surgical →
Sponsor
GATT Technologies BV — full company profile →
Who can join
22 and older, any sex, with Intraoperative Bleeding or Liver Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a pre-market, prospective, randomized (1:1), multicenter, pivotal clinical investigation. The purpose of this investigation is to determine the clinical performance of GATT-Patch as compared with SURGICEL® Original for the management of minimal, mild, or moderate bleeding during minimally invasive liver and gallbladder surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05900037
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of GATT-Patch
Trials testing the same drug.
- NCT04819945 — Clinical Safety and Performance of GATT-Patch in Open Liver Surgery · NA · completed
Other recruiting trials for Intraoperative Bleeding
Currently open trials in the same condition.
- NCT06848764 — Lidocaine and Dexmedetomidine Infusions for Intraoperative Bleeding in Functional Endoscopic Sinus Surgery · NA · recruiting
- NCT06427707 — The Effect of Adding Either Propofol or Ketamine to Magnesium and Lidocaine Infusions in Nasal Surgeries. · Phase 2, PHASE3 · recruiting
- NCT06399445 — Measurement of Blood Loss in Adenotonsillectomy During General Anesthesia According to the Application of Nondepolarizin · Phase 4 · recruiting
Other GATT Technologies BV trials
Trials by the same sponsor.
- NCT05385952 — GATT-Patch Versus TachoSil in Liver Surgery · NA · completed
- NCT04819945 — Clinical Safety and Performance of GATT-Patch in Open Liver Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05900037 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GATT Technologies BV
- Last refreshed: 12 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05900037.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing